Related Experiment Video
Updated: May 15, 2026

Amide Coupling Reaction for the Synthesis of Bispyridine-based Ligands and Their Complexation to Platinum as Dinuclear Anticancer Agents
Published on: May 28, 2014
Cobalt derivatives as promising therapeutic agents
Marie C Heffern1, Natsuho Yamamoto, Robert J Holbrook
1Department of Chemistry, Molecular Biosciences, Neurobiology, Biomedical Engineering, and Radiology, Northwestern University, Evanston, IL 60208-3113, United States.
Cobalt complexes show promise as pharmaceutical agents by targeting proteins and modifying drug activity. Understanding their mechanisms can lead to more effective and specific drug development.
Area of Science:
- Inorganic chemistry
- Medicinal chemistry
- Pharmacology
Background:
- Inorganic complexes offer versatile platforms for developing potent and selective pharmaceutical agents.
- Cobalt's unique properties can be leveraged for creating promising drug candidates.
- Investigating cobalt therapeutic agent mechanisms provides insight into physicochemical properties for drug development.
Purpose of the Study:
- To review bioactive cobalt complexes and their mechanisms of action.
- To highlight cobalt complexes that exert biological effects via protein inhibition, drug activity modification, and bioreductive activation.
- To identify key features of cobalt that can be tuned for targeted therapeutics.
Main Methods:
- Literature review of bioactive cobalt complexes.
- Analysis of mechanisms of action for cobalt-based therapeutics.
- Discussion of specific examples including protein inhibition, drug activity modification, and bioreductive activation.
Main Results:
- Cobalt complexes demonstrate diverse biological activities.
- Mechanisms involve protein inhibition, modulation of existing drug efficacy, and bioreductive activation.
- Specific examples illustrate the potential for targeted therapeutic development.
Conclusions:
- Cobalt complexes are valuable in pharmaceutical development.
- Rational tuning of cobalt properties can enhance specificity and efficacy.
- Understanding mechanisms facilitates the design of novel cobalt-based drugs.
Related Concept Videos
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Pharmaceutical Poisoning: Treatment Strategies
Therapeutic Drug Monitoring: Overview and Classification
Targets for Drug Action: Overview
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Pharmacogenomics: Identification of New Drug Targets
